X-ZELL technology used in development of new T cell therapy Singapore, September 2023 – A research team at Duke-NUS Medical School in Singapore has developed a T cell therapy that could play an important role in treating cancer recurrences after liver transplants. The...
First lab confirmed to introduce X-ZELL Cryoimmunostaining™ into clinical routine Frankfurt, June 2023 – X-ZELL, a pioneering company in the field of next-generation cytology, is proud to announce a strategic collaboration with the Medizinisches Versorgungszentrum für...
Former Roche Diagnostics NAM CEO Michael Tillmann joins X-ZELL executive board Singapore, August 2022 – X-ZELL is proud to announce the appointment of Michael Tillmann as member of the company’s executive board. Drawing on more than 30 years of experience in the...
X-ZELL launches new Imaging Technology unit Singapore, August 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the formation of a new, interdisciplinary Imaging Technology division. The announcement comes on the back of a new collaboration agreement...
X-ZELL announces strategic expansion into Europe Lennestadt, February 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the opening of a new international office in Germany. Recently voted the second-most innovative health-tech start-up in the world1,...
